Citigroup’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-218,200
Closed -$46.4M 7876
2014
Q4
$46.4M Sell
218,200
-700
-0.3% -$139K 0.04% 432
2014
Q3
$39M Buy
218,900
+2,800
+1% +$465K 0.03% 489
2014
Q2
$36.6M Buy
216,100
+117,200
+119% +$18.2M 0.04% 477
2014
Q1
$12.3M Sell
98,900
-287,300
-74% -$35M 0.01% 1016
2013
Q4
$42.9M Buy
386,200
+221,000
+134% +$21.1M 0.04% 426
2013
Q3
$14.9M Sell
165,200
-47,800
-22% -$4.29M 0.01% 883
2013
Q2
$17.9M Buy
+213,000
New +$22.1M 0.02% 731

Other funds holding AGN

Citigroup's AGN Position: Q1 2015 in Review

Citigroup sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 98,646 shares — an estimated $21M sold.

Citigroup first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $29.4M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Citigroup reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 98,646 Allergan Inc shares in Q1 2015, an estimated $21M.
  • Citigroup first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Citigroup's Allergan Inc position peaked at $29.4M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.